A STUDY ON THE PREVALENCE AND RISK FACTORS FOR HYPOTHYROIDISM IN LITHIUM TREATED BIPOLAR DISORDER PATIENTS
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 19
Abstract
BACKGROUND Lithium is a novel mood stabilizer in the treatment of bipolar disorders. Toxic effects are frequently encountered in clinical practice due to its narrow therapeutic index. Thyrostatic effects especially clinical hypothyroidism, is a well-known side effect of long term lithium treatment and has been reported in medical literature. However, Indian studies on this major issue is sparse. The aim of the study was to evaluate the prevalence and risk factors for the onset of hypothyroidism (overt and subclinical) in bipolar disorder patients treated with lithium. MATERIALS AND METHODS 110 patients who fulfilled the study criteria were taken from inpatient and outpatient departments of Institute of Mental Health and assessed for prevalence of hypothyroidism (clinical and subclinical) based on thyroid function test taken from case records (T3, T4, TSH). Retrospective analysis of risk factors like age, sex, weight gain during lithium intake, family history of thyroid disease, dose and duration of lithium intake and onset of hypothyroidism was done. RESULTS In our study, the prevalence of overt and subclinical hypothyroidism in bipolar patients treated with lithium was 32.7% and 15.5% respectively. Strong association was present between the risk factors (female sex, age group of 51-60 years of age, positive family history, and weight gain during lithium intake) and onset of overt hypothyroidism. Subclinical hypothyroidism developed within 1-3 yrs. at a dose of 900mg of lithium per day and overt hypothyroidism took >3 yrs. to manifest at a dose of 1200mg of lithium after the start of treatment. CONCLUSION Hypothyroidism in bipolar patients worsens the mood symptoms, leads to cognitive impairment and alters the response to psychotropic drugs. It calls for a mandatory drug review, along with baseline and periodic thyroid function test especially in high risk cases. Early intervention with thyroxin supplementation improves the patient mood and wellbeing.
Authors and Affiliations
Vishalakshi L. , Hemapriya M. G.
Keywords
Related Articles
- EP ID EP557426
- DOI 10.18410/jebmh/2018/330
- Views 61
- Downloads 0
PLACENTAL SIZE AND PERINATAL OUTCOMES
BACKGROUND: The human placenta, a transient organ or pregnancy provides information about fetal well-being and pregnancy outcome. AIMS: To study the placental ultrasound characters in relation to perinatal outcomes. SETT...
A STUDY OF RELATION OF RECURRENT LARYNGEAL NERVE TO INFERIOR THYROID ARTERY AND THYROID GLAND
BACKGROUND The recurrent laryngeal nerve is one of the constant branches of vagus nerve. In this study, our aim is to find out the variations of recurrent laryngeal nerve by dissecting the neck of 25 cadavers. Aim of the...
COMPARATIVE STUDY OF ARTHROSCOPIC SINGLE BUNDLE ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND NON-ANATOMICAL DOUBLE BUNDLE WITH SINGLE TIBIAL TUNNEL ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION WITH SEMITENDINOSUS ± GRACILIS AUTOGRAFTS USING LAXOMETRY
BACKGROUND The knee joint is the most commonly injured of all joints and the ACL is the most commonly injured ligament. Arthroscopic reconstruction of ACL has become gold standard in treating these injuries. AIM 1. To co...
PROGNOSTICATION OF SOFT TISSUE SARCOMAS
BACKGROUND Soft tissue sarcomas (STS) account for less than 1% of all malignant tumours but present a significant diagnostic and therapeutic challenge since there are more than 50 histological subtypes.1 The clinical cou...
A STUDY OF BENIGN TUMOURS OF THE PAROTID GLAND
BACKGROUND The Salivary glands are located around the mouth. They produce saliva, which moistens food to help chewing and swallowing. There are three pairs of major Salivary Glands. The largest are the Parotid Glands and...